RIMAG GROUP's stock soared 5.31% during intraday trading on Monday, following the company's announcement of a strategic acquisition to enhance its position in the medical imaging AI sector.
The company revealed plans to acquire 100% equity interests in two target companies, Hong Kong Sun Seeds Management Co and Wingon Medical Technology, for a total consideration of approximately HK$353 million. These target companies hold stakes in Medical Image Insights (also referred to as Yinghe Yimai), a firm specializing in medical imaging AI technology.
Upon completion of the acquisition, RIMAG GROUP's effective interest in Medical Image Insights will increase to about 25.4%. The move is seen as a strategic step to strengthen the company's underlying AI technological capabilities and solidify its leadership in the domestic medical imaging AI industry, aligning with its long-term development plan.
Comments